Aug 2026· ACS Applied Bio Materials· Vol 9 16, pp.
7269-7283
· 0 citations· 67 references
Medicine
TL;DR
The present study suggests that photo-responsive polypeptide PNFs represent a promising and versatile therapeutic strategy for combating antibiotic-resistant bacterial infections, owing to their dual functional capabilities.
Abstract
Therapeutic interventions for bacterial infections are increasingly challenging due to the growing threat of antibiotic resistance, particularly from Methicillin-resistant Staphylococcus aureus (MRSA), which poses significant risks to global health. Generally, MRSA has a high mortality rate and can lead to severe illnesses such as sepsis and pneumonia, mainly due to the lack of effective treatments and growing drug resistance. To this end, the present study introduces azobenzene-conjugated photo-responsive polypeptide nanofibers (PNFs) that mimic host-defense peptides to combat antibiotic-resistant bacterial pathogens. We show that incorporating an azobenzene moiety into the PNF enables light-mediated control via photoinduced conformational changes. The polypeptide structure incorporates these azobenzene units, synthesized via ring-opening polymerization (ROP) of N-carbobenzoxy-l-lysine N-carboxyanhydride (Cbz-l-Lys NCA) with NAP-AZO as the initiator. Moreover, we show that conformational changes in the PNF affect its interactions with bacterial membranes. While the azobenzene moieties provide light-regulated activity, the amino groups from lysine enhance electrostatic membrane disruption. This has resulted in effective membrane interaction of PNFs, facilitating the generation of reactive oxygen species (ROS) against MRSA, which are crucial for bacterial death or growth inhibition. Overall, the present study suggests that photo-responsive polypeptide PNFs represent a promising and versatile therapeutic strategy for combating antibiotic-resistant bacterial infections, owing to their dual functional capabilities.
In an MRSA-infected wound model, PK4-mediated phototherapy can reduce inflammation, accelerate wound healing, and enhance collagen deposition without systemic toxicity, providing a promising aPDT strategy for combating drug-resistant bacterial infections.
Yan Zeng, Huijiao Tang, Xinyu Wu et al.· Molecular Pharmaceutics· 0 citations
A hierarchical, stimuli-responsive nanomedicine designed on principles of safety, specificity, switchability, and synergy is reported, offering a universal strategy to treat diverse, multidrug-resistant infections.
R. Gao, Hongbing Liu, Wan-Bo Zhu et al.· Bioactive Materials· 0 citations
Self-assembling, tryptophan-rich peptide nanofibrils derived from DVFLGREEWWWWC (D4W) are introduced as potent antibacterial agents against Staphylococcus species, including MRSA, and their efficacy was validated in ex vivo pig skin and in vivo zebrafish embryo models.
The determination and comparison of the MIC50 values of the selected TC compounds identified molecules exhibiting increased activity resulting from a conformational change under UVA exposure.
Amélie Aubert, A. Fayeulle, M. Vayssade et al.· Photochemical and Photobiolo...· 0 citations
Dendrimers, synthetic, highly branched nanostructures with well-defined architecture and tunable surface functionality, have come as promising multi-target antimicrobial systems that allow dendrimers to overcome multiple bacterial resistance mechanisms simultaneously.
S. Arya, Arshnoor Kaur, Jatin Kaushik et al.· Drug Delivery Letters· 0 citations
In bacterial-induced mouse models of epidermal and keratitis infections, cHH8-6 effectively reduces the bacterial count at the infection site with negligible in vivo toxicity, and due to its unique mechanism, cHH8-6 is less likely to induce bacterial resistance compared to clinical antibiotics.
Zhe Zong, Guowenlie Gao, Pengqi Wan et al.· Biomaterials Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.